InVivoMAb anti-mouse CD11c

CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells.

Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.

Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells. Matsuo H et al., 2012, Int J Nanomedicine

Trogocytosis of CD80 and CD86 by induced regulatory T cells.

Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses.

CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. Sadhu C et al., 2007 Jun, J Leukoc Biol

Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells.

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.

Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection.